[
    [
        {
            "time": "2018-10-17",
            "original_text": "Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS",
            "features": {
                "keywords": [
                    "Health Care",
                    "Sector Update",
                    "TEVA",
                    "ESRX",
                    "AMGN"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Health Care Sector Update for 10/17/2018: TEVA,ESRX,AMGN,NVW,LLY,VTVT,KDMN,FMS",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 5,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva",
            "features": {
                "keywords": [
                    "Express Scripts",
                    "Amgen",
                    "Lilly",
                    "migraine drugs",
                    "excludes Teva"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva",
            "features": {
                "keywords": [
                    "Express Scripts",
                    "Amgen",
                    "Lilly",
                    "migraine drugs",
                    "excludes Teva"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "Stocks - Netflix Soars in Pre-market; IBM, Tilray, Canopy Growth Sink; Tesla Rises",
            "features": {
                "keywords": [
                    "Netflix",
                    "Pre-market",
                    "IBM",
                    "Tilray",
                    "Canopy Growth",
                    "Tesla"
                ],
                "sentiment_score": 0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology",
                    "cannabis",
                    "automotive"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Stocks - Netflix Soars in Pre-market; IBM, Tilray, Canopy Growth Sink; Tesla Rises",
                "Correlation": 3,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off",
            "features": {
                "keywords": [
                    "Teva Pharmaceutical",
                    "Sell-Off",
                    "Negative"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Teva Pharmaceutical Remains Firmly Negative After Early Sell-Off",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-10-17",
            "original_text": "5 Blue Chip Drug Stocks Poised for Long-Term Gains",
            "features": {
                "keywords": [
                    "Blue Chip",
                    "Drug Stocks",
                    "Long-Term Gains"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "5 Blue Chip Drug Stocks Poised for Long-Term Gains",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]